The National Pharmaceutical Regulatory Agency (NPRA) of Malaysia accepted WHO GMP certificate issued by the Animal and Plant Health Inspection Agency (APHIA) of Taiwan.

Since the company was founded in 2016, Vetnostrum is not only focused on product sales in domestic but also cooperated with foreign partners for registration of animal drugs and supplements.

In 2019, Vetnostrum has established its own injectable production line. In response to meet the increasingly strict GMP requirements in Southeast Asia countries, Vetnostrum entrusted the Animal and Plant Health Inspection Agency (APHIA), Ministry of Agriculture referring to WHO GMP guideline to inspect all hardware and software design, optimize product development and manufacturing, re-plan and implement validation for injectable production line. After years of effort, Vetnostrum finally acquired WHO GMP certificate issued by APHIA in November 2023.

With the injectable product registration in Malaysia, Vetnostrum submitted the WHO GMP certificate and related inspection report to National Pharmaceutical Regulatory Agency (NPRA) of Malaysia in the end of 2023. Later in Apr 2024, the NPRA notified the acceptance of WHO GMP certificate issued by the APHIA of Taiwan.

Vetnostrum as the first and the only WHO GMP animal pharmaceutical factory in Taiwan, now is also recognized by the NPRA of Malaysia, which represents Vetnostrum’s products are in line with international GMP standards. This will help Vetnostrum accelerate product registrations abroad, greatly save time of acquiring product licenses, and successfully promote Taiwan's high-quality animal drugs to overseas markets.

(The NPRA of Malaysia sent email notification: Acceptance of WHO GMP certificate issued by APHIA of Taiwan)

►Notification from NPRA, Malaysia

►Translated version